MIDDLETON, Wis., March 5, 2026 /PRNewswire/ -- Natus Medical Incorporated has announced the global launch of the autoSCORE™ analysis tool, spreading the availability of the first artificial-intelligence model capable of automatic and comprehensive clinical EEG interpretations while providing accuracy on par with medical experts.

With its introduction to the United States market in August 2024 for routine EEG studies, U.S. neuro care teams became the first to experience the benefits of autoSCORE, which alleviated the demands on clinical resources and staff through a deep-learning model developed in Norway by Holberg EEG and trained on 30,000 expertly labeled EEG recordings. Offered exclusively with Natus NeuroWorks software, autoSCORE is FDA 510(k) cleared for an expanded indication to include routine EEG, LTM and Ambulatory EEG studies. It has also received the CE mark for European and other international markets.

"Developing the first AI model capable of interpreting clinical EEGs at the level of the world's top experts marks a defining moment for both Natus and the field of neurodiagnostics," said Chris Landon, CEO of Natus Neuro. "Now, we're proud to bring this breakthrough innovation to healthcare providers globally - advancing our mission to expand patient access and deliver life-changing outcomes through cutting-edge neuro solutions."

Early adopters welcomed the confidence provided by the ability of autoSCORE to go beyond traditional spike and seizure detectors, assessing multiple clinically relevant abnormalities and providing study-level assessments to inform healthcare providers if an EEG study is normal or abnormal. They also found comfort in its closed AI model, which ensures consistency and security.

"Human teaming with intelligent machines has become a fundamental characteristic of a successful clinical decision support system," said Dr. Ram Mohan Sankaraneni, a board-certified neurologist and fellow of the American Epilepsy Society and the American Academy of Neurology. "(autoSCORE) is a reliable colleague that can provide a second opinion... a powerful pathway to faster interventions."

Visual EEG review is considered the gold standard for determining abnormalities, but it can strain department resources. The AI-enabled autoSCORE application is designed to allow teams to more efficiently and consistently perform EEG data analysis.

ABOUT NATUS

Natus is trusted by healthcare providers around the globe as the solution source to screen, diagnose, and treat disorders affecting the brain and neural pathways. The best-in-class Natus solutions, including service, field support and education, enable clinicians to advance their standard of care, improving patient outcomes and quality of life. For more information on Natus, visit natus.com/neuro.

CONTACT INFORMATION:
Lisa Schuler
Phone: +1 612 528-1332
Email: lisa.schuler@natus.com

Video - https://mma.prnewswire.com/media/2926890/autoSCORE_Global_Chris_Landon.mp4
Photo - https://mma.prnewswire.com/media/2926889/autoSCORE_Sankaraneni_Quote.jpg
Logo - https://mma.prnewswire.com/media/2477077/5838090/Natus_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/natus-expands-availability-to-expert-level-review-of-eeg-with-global-launch-of-autoscore-ai-analysis-tool-302705444.html

Images

Tags

More Like This

Natus expands access to autoSCORE AI analysis through BRAIN QUICK Software

Natus introduces AVEMG innovation in launch of latest edition of Natus Elite software

Clario's New AI-Powered ECG Quality Score Tool Enhances Cardiac Safety Assessments

PulseAI's Groundbreaking AI Algorithm Enhances Consumer ECG Diagnostics

Cumulus Neuroscience and Muse by Interaxon Bring Validated At-Home Sleep EEG to CNS Clinical Trials

Neusoft Medical Systems Showcases AI-powered Medical Imaging Solutions at RSNA 2024

AI/ML Innovations' Subsidiary NeuralCloud Achieves ISO 13485:2016 (MDSAP) Certification

ConcertAI's TeraRecon Launches Three New Care Suites, Life Sciences Platform, and Strategic Partnerships at #ECR24